Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hemminki Kari) "

Sökning: WFRF:(Hemminki Kari)

Sortera/gruppera träfflistan
  • Bermejo, Justo Lorenzo, et al. (författare)
  • Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden
  • 2014
  • Ingår i: British Journal of Haematology. - Federation of European Neuroscience Societies and Blackwell Publishing Ltd. - 0007-1048. ; 164:5, s. 675-683
  • Tidskriftsartikel (refereegranskat)abstract
    • Survival after non-Hodgkin lymphoma (NHL) has increased thanks to improved treatment but NHL survivors have an increased risk of second neoplasms. The assessment of cancer risk patterns after NHL may help to quantify the late side-effects of therapy. Poisson regression was used to estimate relative risks (RRs) and absolute incidence rates for nine solid tumours based on a nationwide cohort of 60 901 NHL survivors from Finland, Norway and Sweden. Patients were diagnosed between 1980 and 2006 and developed 6815 s neoplasms. NHL patients showed an increased risk of each of the nine investigated cancer sites: prostate and pancreas (both RRs 1.28), breast (1.37), colorectum (1.48), urinary bladder (1.52), stomach and lung (both RRs 1.87), skin (melanoma 2.27) and kidney (2.56). The RRs showed a U-shaped relationship with time after NHL for all nine-second cancer types. NHL diagnosis early in life was a risk factor for the development of second cancers with the exception of melanoma, but a risk excess was even observed in patients diagnosed with NHL at age 80+ years. The present study provides accurate estimates on the adverse late effects of NHL therapy, which should guide the establishment of cancer prevention strategies in NHL survivors.
  • Bevier, Melanie, et al. (författare)
  • Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer?
  • 2011
  • Ingår i: European Journal of Cancer. - Elsevier. - 1879-0852. ; 47:4, s. 586-591
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Age at first and last birth and the number of children are known to influence the risk of endometrial and ovarian cancers. However, it remains unknown whether the difference in years between first and last childbirth plays a role. The Swedish Family-Cancer Database allowed us to carry out the largest study ever on reproductive factors in these cancers. Material and methods: We selected over 5.7 million women from the database. We estimated the effect of number of children, age at birth and difference between age at first and last birth by Poisson regression adjusted for age, period, region and socioeconomic status. Results: The risk for endometrial cancer is negatively associated with increasing number of children and increasing age at first as well as age at last birth. Weaker associations are found for ovarian cancer. Age at last birth is the factor that shows highest influence. A large difference in first and last childbirth shows a protective effect on the risk of endometrial cancer. Conclusion: Our findings suggest that the risk of endometrial cancer is significantly decreased for women having at least a difference of 10 years between their first and last birth. Ovarian cancer does not seem to be influenced by the time interval between first and last birth. (c) 2010 Elsevier Ltd. All rights reserved.
  • Bevier, Melanie, et al. (författare)
  • Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
  • 2012
  • Ingår i: European Journal of Cancer Prevention. - Lippincott Williams & Wilkins. - 1473-5709. ; 21:6, s. 596-601
  • Tidskriftsartikel (refereegranskat)abstract
    • Increasing incidences of cancer of unknown primary (CUP) have been observed in Sweden previously. However, it is not known how the incidence trends for specific locations of metastasis vary. Site-specific data are available on the basis of the ninth international classification of diseases. CUP patients were identified between 1987 and 2008 from the Swedish Family-Cancer Database. Malignant neoplasms of ill-defined sites were diagnosed in 4042 patients, 1976 developed metastasis in lymph nodes, 9615 had metastasis in specified organs, and in 8052 patients, the malignant neoplasm was diagnosed without further specification. Age-standardized incidence rates for 23 685 patients were analyzed using a direct method of standardization. Overall, the incidence of CUP decreased from 6.98 to 6.00 per 100 000 from 1987 to 2008. The number of patients diagnosed with metastasis in specified organs decreased, whereas the number of patients diagnosed with CUP without further specification increased from 2.65 to 3.02 per 100 000. With improvements in diagnostic methods and imaging techniques for identification of cancer, the incidences of CUP have been decreasing because primary tumors can be specified more often. Computed tomography is typically sensitive in detecting lung, kidney, and colorectal cancers, which are known to have a genetic link with CUP. Prostate-specific antigen testing is used to detect prostate cancer, for which bone is a common metastatic site. Liver metastases are common if the primary tumor is located in the colorectum. If the primary tumor is found, this cancer site replaces the diagnosis of CUP within the Cancer Register and therefore CUP incidence is decreased.
  • Bevier, Melanie, et al. (författare)
  • Influence of family size and birth order on risk of cancer: a population-based study
  • 2011
  • Ingår i: BMC Cancer. - BioMed Central. - 1471-2407. ; 11
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Family size and birth order are known to influence the risk of some cancers. However, it is still unknown whether these effects change from early to later adulthood. We used the data of the Swedish Family Cancer Database to further analyze these effects. Methods: We selected over 5.7 million offspring with identified parents but no parental cancer. We estimated the effect of birth order and family size by Poisson regression adjusted for age, sex, period, region and socioeconomic status. We divided the age at diagnosis in two groups, below and over 50 years, to identify the effect of family size and birth order for different age periods. Results: Negative associations for increasing birth order were found for endometrial, testicular, skin, thyroid and connective tissue cancers and melanoma. In contrast, we observed positive association between birth order and lung, male and female genital cancers. Family size was associated with decreasing risk for endometrial and testicular cancers, melanoma and squamous cell carcinoma; risk was increased for leukemia and nervous system cancer. The effect of birth order decreased for lung and endometrial cancer from age at diagnosis below to over 50 years. Combined effects for birth order and family size were marginally significant for thyroid gland tumors. Especially, the relative risk for follicular thyroid gland tumors was significantly decreased for increasing birth order. Conclusion: Our findings suggest that the effect of birth order decreases from early to late adulthood for lung and endometrial cancer.
  • Bevier, Melanie, et al. (författare)
  • Risk of breast cancer in families of multiple affected women and men
  • 2012
  • Ingår i: Breast Cancer Research and Treatment. - Springer. - 1573-7217. ; 132:2, s. 723-728
  • Tidskriftsartikel (refereegranskat)abstract
    • Family history of first and second-degree relatives is known to increase the risk for breast cancer. Less data are available on the risks between defined multiple affected close and distant relatives for which the reliability of data may be an issue. Data on affected males are sparse. These questions and the probable genetic models were addressed in this study by means of a nationwide Swedish Family-Cancer Database. We estimated the effect of family history of breast cancer by Poisson regression for women of at least 30 years of age after adjusting for age, period, region, socioeconomic status, number of children, and age at first birth. The results of the study showed that relative risk (RR) for breast cancer was associated with a first degree as well as second-degree family history. Having at least two female affected first-degree relatives increased the RR at least to 2.8, favoring an additive interaction. The risk was increased around ten times in women with both parents affected. When either a father or a mother was affected, the RRs were nearly identical (RR = 1.73 and 1.74, respectively). The RR for a woman increased more when a brother was affected (RR = 2.48) compared to when a sister was affected (RR = 1.87). Having an affected grandmother showed lower familial excess risks than having an affected half sister (RR = 1.27, and 1.26; and RR = 1.39, and 1.50; respectively, for maternal and paternal relatives). We concluded that when both parents were diagnosed with breast cancer, the risk for the daughter was increased tenfold. Having an affected brother showed a somewhat higher risk than having an affected sister. The data suggest that male breast cancer has a higher genetic basis than female breast cancer, which invites further search of the underlying mechanisms.
  • Bosetti, Cristina, et al. (författare)
  • High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries
  • 2011
  • Ingår i: International Journal of Cancer. - John Wiley and Sons Inc.. - 0020-7136. ; 129:1, s. 173-179
  • Tidskriftsartikel (refereegranskat)abstract
    • Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head and neck (HN) and its pattern with age. We investigated this issue using data from a multicentric study of 13 population-based cancer registries from Europe, Canada, Australia and Singapore for the years 1943-2000. A total of 99,257 patients had a first primary HN cancer (15,985 tongue, 22,378 mouth, 20,758 pharyngeal, and 40,190 laryngeal cancer), contributing to 489,855 person-years of follow-up. A total of 1,294 of the patients (1.3%) were diagnosed with second HN cancers (342 tongue, 345 mouth, 418 pharynx and 189 larynx). Male incidence rates of first HN cancer steeply increased from 0.68/100,000 at age 30-34 to 46.2/100,000 at age 70-74, and leveled off at older age; female incidence increased from 0.50/100,000 at age 30-34 to 16.5/100,000 at age 80-84. However, age-specific incidence of second HN cancers after a first HN cancer in men was around 200-300/100,000 between age 40-44 and age 70-74 and tended to decline at subsequent ages (150/100,000 at age 80-84); in women, incidence of second HN cancers was around 200-300/100,000 between age 45-49 and 80-84. The patterns of age-specific incidence were consistent for different subsites of second HN cancer and sexes; moreover, they were similar for age-specific incidence of first primary HN cancer in patients who subsequently developed a second HN cancer. The incidence of second HN cancers does not increase with age, but remains constant, or if anything, decreases with advancing age.
  • Brandt, Andreas, et al. (författare)
  • Age at Diagnosis and Age at Death in Familial Prostate Cancer
  • 2009
  • Ingår i: Oncologist. - AlphaMed Press. - 1083-7159. ; 14:12, s. 1209-1217
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives. A family history of prostate cancer is associated with a higher risk for prostate cancer to first-degree relatives. If greater surveillance of men at familial risk is considered to be useful, population-based estimates of the differences in the age at diagnosis between familial and sporadic prostate cancer cases are needed. Methods. The men in the nationwide Swedish Family-Cancer Database were classified according to the number and type of affected first-degree relatives (father or brother) and according to the relative's age at diagnosis. The cumulative incidence of prostate cancer and cumulative prostate cancer-specific mortality were estimated using a stratified Cox model. Results. The cumulative incidence was highest for men with multiple affected first-degree relatives, and it was higher for brothers than for sons of prostate cancer patients. The age to reach the same cumulative incidence as the general population at age 55 years decreased with decreasing age at diagnosis of the relative, ranging from 48.7 years (father diagnosed before 60 years of age) to 53.7 years (father diagnosed after 82 years of age). Prostate cancer-specific mortality was also related to the number and type of affected relatives but there was no clear evidence for a dependency on the age at diagnosis of the relative. Conclusions. Men with a father or a brother affected by prostate cancer are diagnosed and die at earlier ages than men without a family history of prostate cancer. This study should encourage further analysis in order to assess the risks and benefits of screening for prostate cancer in men at higher risk. The Oncologist 2009; 14: 1209-1217
  • Brandt, A., et al. (författare)
  • Age of onset in familial breast cancer as background data for medical surveillance
  • 2010
  • Ingår i: British Journal of Cancer. - Nature Publishing Group. - 1532-1827. ; 102:1, s. 42-47
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Familial breast cancers are known to be of early onset. This article provides differences in the age of onset of breast cancer and death by breast cancer between women with and without a family history. METHODS: The Swedish Family-Cancer Database was used to estimate the cumulative risk of breast cancer and death by breast cancer according to family history with a stratified Cox model. Family history was defined separately for affected mother or sister considering their diagnostic ages. RESULTS: The age to reach the same cumulative incidence as women without family history decreased with decreasing diagnostic age of the affected relative. Women with a maternal history reached the risk of women lacking a family history at the age of 50 years between 12.3 (mother affected < 40 years) and 3.3 years (mother affected > 82 years) earlier. The trend for breast cancer mortality was essentially similar. CONCLUSIONS: Women with mother or sister affected by breast cancer are diagnosed and die at earlier ages than do women without family history. The differences depend on the diagnostic age of the affected relative. The present data may provide a rationale to derive recommendations for the starting age of screening in women with affected family members. British Journal of Cancer (2010) 102, 42-47. doi:10.1038/sj.bjc.6605421 www.bjcancer.com Published online 10 November 2009 (C) 2010 Cancer Research UK
Skapa referenser, mejla, bekava och länka
fritt online (116)
Typ av publikation
tidskriftsartikel (466)
forskningsöversikt (6)
konferensbidrag (3)
Typ av innehåll
refereegranskat (457)
övrigt vetenskapligt (48)
Hemminki, Kari, (475)
Sundquist, Jan, (182)
Försti, Asta, (180)
Sundquist, Kristina, (152)
Li, Xinjun, (81)
Ji, Jianguang, (76)
visa fler...
Thomsen, Hauke, (36)
Lenner, Per, (35)
Hoffmann, Per (33)
Houlston, Richard S. (33)
Fallah, Mahdi, (32)
Goldschmidt, Hartmut ... (31)
Hemminki, Akseli, (29)
Kumar, Rajiv (28)
Weinhold, Niels, (27)
Vodicka, Pavel, (27)
Mousavi, Seyed Mohse ... (27)
Chen, Bowang (26)
Vodickova, Ludmila, (25)
Brandt, Andreas (22)
da Silva Filho, Migu ... (22)
Liu, Xiangdong, (21)
Chattopadhyay, Subha ... (21)
Naccarati, Alessio, (20)
Zheng, Guoqiao, (18)
Johansson, Robert, (17)
Nöthen, Markus M (17)
Yu, Hongyao, (17)
Sud, Amit, (17)
Kharazmi, Elham (17)
Houlston, Richard (16)
Forsti, A (16)
Bevier, Melanie (16)
Broderick, Peter (16)
Morgan, Gareth J. (16)
Henriksson, Roger, (15)
Hemminki, Otto, (15)
Chen, Tianhui (15)
Enquist, Kerstin, (14)
Bermejo, Justo Loren ... (14)
Hallmans, Göran, (13)
Johnson, David C. (13)
Pardini, Barbara (13)
Huhn, Stefanie, (13)
Brenner, Hermann (12)
Canzian, Federico (12)
Jöckel, Karl-Heinz (12)
Pukkala, Eero, (12)
Frank, Christoph, (12)
Shu, Xiaochen, (12)
visa färre...
Lunds universitet (453)
Karolinska Institutet (82)
Umeå universitet (42)
Uppsala universitet (10)
Göteborgs universitet (9)
Stockholms universitet (2)
Engelska (470)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (433)
Naturvetenskap (2)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy